Compare Zhongzhi Pharmaceutical Holdings Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 12.09%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 24.50
3
Poor long term growth as Operating profit has grown by an annual rate -11.90% of over the last 5 years
4
Negative results in Dec 25
5
With ROE of 1.88%, it has a Very Attractive valuation with a 0.59 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.41%
0%
5.41%
6 Months
34.48%
0%
34.48%
1 Year
-13.33%
0%
-13.33%
2 Years
-32.17%
0%
-32.17%
3 Years
-30.36%
0%
-30.36%
4 Years
-22.0%
0%
-22.0%
5 Years
-45.45%
0%
-45.45%
Zhongzhi Pharmaceutical Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.26%
EBIT Growth (5y)
-11.90%
EBIT to Interest (avg)
24.50
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.60
Tax Ratio
34.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.58%
ROE (avg)
12.09%
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
0.59
EV to EBIT
7.90
EV to EBITDA
3.87
EV to Capital Employed
0.61
EV to Sales
0.35
PEG Ratio
NA
Dividend Yield
618.52%
ROCE (Latest)
7.68%
ROE (Latest)
1.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,884.30
2,401.30
-21.53%
Operating Profit (PBDIT) excl Other Income
115.70
240.60
-51.91%
Interest
5.80
7.60
-23.68%
Exceptional Items
2.60
-5.60
146.43%
Consolidate Net Profit
19.20
104.20
-81.57%
Operating Profit Margin (Excl OI)
2.40%
56.80%
-5.44%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -21.53% vs 6.02% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -81.57% vs -42.56% in Dec 2024
About Zhongzhi Pharmaceutical Holdings Ltd. 
Zhongzhi Pharmaceutical Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






